Table: Taiko Pharmaceutical -2019/20 group results

Taiko Pharmaceutical

12/05/2020 07:00

May 12 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended      9 months to       NEXT   
                Mar 31, 2020    Mar 31, 2019     Dec 31, 2020      YEAR     
                   LATEST         YEAR-AGO         COMPANY        COMPANY   
                   RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales             14.97           10.42           13.50                   
                 (+43.6 pct)     (+10.1 pct)                                
  Operating          3.82            2.03            3.70                   
                 (+88.4 pct)     (+9.3 pct)                                 
  Recurring          3.63            1.89            3.50                   
                 (+92.7 pct)     (+20.2 pct)                                
  Net
  Net                2.45            1.42            2.50                   
                 (+73.3 pct)     (+29.3 pct)                                
  EPS             57.57 yen       33.00 yen       58.23 yen                 
  EPS Diluted     57.34 yen       32.96 yen                                 
  Ann Div         50.00 yen       35.00 yen       17.00 yen                 
  -Q2 Div         10.00 yen       10.00 yen        7.00 yen                 
  -Q4 Div         40.00 yen       25.00 yen       10.00 yen                 
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T